Advertisement
Screener

RELMADA THERAPEUTICS, INC. (RLMD) Depreciation

2.8 / 5 stars · 68/120 Roast Me

RELMADA THERAPEUTICS, INC. Depreciation

RELMADA THERAPEUTICS, INC. (RLMD) reported Depreciation of $1.26 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-23.

Discontinued › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2023-03-23

  • RELMADA THERAPEUTICS, INC. depreciation for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. depreciation for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. depreciation for the quarter ending 2021-06-30 was $452.00, a 56.07% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. depreciation for the quarter ending 2021-03-31 was $806.00, a 22.94% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. depreciation for fiscal 2021 was $1.26K, a 66.47% decline from fiscal 2020.
  • RELMADA THERAPEUTICS, INC. depreciation for fiscal 2020 was $3.75K, a 14.00% decline from fiscal 2019.
  • RELMADA THERAPEUTICS, INC. depreciation for fiscal 2019 was $4.36K.
  • RELMADA THERAPEUTICS, INC. depreciation for fiscal 2019 was $4.87K, a 85.38% increase from fiscal 2018.
Period endDepreciation 3 monthDepreciation 6 monthDepreciation 9 monthDepreciation 12 monthDepreciation 115 monthDepreciation 118 month
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$0.00
derived: sum of 2 quarters · filed 2023-03-23
$452.00
derived: sum of 3 quarters · filed 2023-03-23
$1.26K
10-K · filed 2023-03-23
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$452.00
derived: sum of 2 quarters · filed 2022-11-10
$1.26K
10-Q · filed 2022-11-10
$2.08K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$452.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.26K
10-Q · filed 2022-08-11
$2.08K
derived: sum of 3 quarters · filed 2022-08-11
$2.94K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$806.00
10-Q · filed 2022-05-05
$1.63K
derived: sum of 2 quarters · filed 2022-05-05
$2.48K
derived: sum of 3 quarters · filed 2022-05-05
$3.51K
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$823.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
$1.68K
derived: sum of 2 quarters · filed 2022-03-25
$2.71K
derived: sum of 3 quarters · filed 2022-03-25
$3.75K
10-K · filed 2022-03-25
2020-09-30$854.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$1.88K
derived: sum of 2 quarters · filed 2021-11-12
$2.93K
10-Q · filed 2021-11-12
$4.03K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$1.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$2.08K
10-Q · filed 2021-08-10
$3.17K
derived: sum of 3 quarters · filed 2021-08-10
$4.28K
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$1.05K
10-Q · filed 2021-05-12
$2.15K
derived: sum of 2 quarters · filed 2021-05-12
$3.25K
derived: sum of 3 quarters · filed 2021-05-12
$4.33K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$1.10K
derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24
$2.20K
10-K · filed 2021-03-24
$3.29K
derived: sum of 3 quarters · filed 2021-03-24
$4.36K
10-K · filed 2021-03-24
2019-09-30$1.10K
10-Q · filed 2019-11-13
$2.19K
derived: sum of 2 quarters · filed 2020-08-12
$3.26K
10-Q · filed 2020-11-12
$4.57K
derived: sum of 4 quarters · filed 2020-08-12
2019-06-30$1.09K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$2.16K
10-Q · filed 2020-08-12
$3.46K
derived: sum of 3 quarters · filed 2020-08-12
$4.87K
10-K · filed 2021-03-24
2019-03-31$1.07K
10-Q · filed 2020-05-15
$2.38K
derived: sum of 2 quarters · filed 2020-05-15
$3.78K
10-Q · filed 2019-05-15
$4.71K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$1.30K
derived: 10-KT 6 month − 10-Q 3 month · filed 2020-03-26
$2.71K
10-KT · filed 2020-03-26
$3.64K
derived: sum of 3 quarters · filed 2020-03-26
$4.20K
derived: sum of 4 quarters · filed 2020-03-26
2018-09-30$1.41K
10-Q · filed 2019-11-13
$2.33K
derived: sum of 2 quarters · filed 2020-03-26
$2.90K
derived: sum of 3 quarters · filed 2020-03-26
$3.48K
derived: sum of 4 quarters · filed 2020-03-26
2018-06-30$929.00
derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26
$1.50K
derived: sum of 2 quarters · filed 2020-03-26
$2.08K
derived: sum of 3 quarters · filed 2020-03-26
$2.63K
10-KT · filed 2020-03-26
2018-03-31$568.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15
$1.15K
derived: sum of 2 quarters · filed 2019-05-15
$1.70K
10-Q · filed 2019-05-15
$19.96K
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$582.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13
$1.13K
10-Q · filed 2019-02-13
$19.39K
derived: sum of 3 quarters · filed 2019-02-13
$42.66K
derived: sum of 4 quarters · filed 2019-02-13
2017-09-30$548.00
10-Q · filed 2018-11-13
$18.81K
derived: sum of 2 quarters · filed 2018-11-13
$42.08K
derived: sum of 3 quarters · filed 2018-11-13
$65.66K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$18.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28
$41.53K
derived: sum of 2 quarters · filed 2018-09-28
$65.11K
derived: sum of 3 quarters · filed 2018-09-28
$85.27K
10-K · filed 2018-09-28
2017-03-31$23.27K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14
$46.85K
derived: sum of 2 quarters · filed 2018-05-14
$67.01K
10-Q · filed 2018-05-14
$88.35K
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$23.58K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12
$43.74K
10-Q · filed 2018-02-12
$65.08K
derived: sum of 3 quarters · filed 2018-02-12
$92.66K
derived: sum of 4 quarters · filed 2018-02-12
2016-09-30$20.16K
10-Q · filed 2017-11-14
$41.50K
derived: sum of 2 quarters · filed 2017-11-14
$69.07K
derived: sum of 3 quarters · filed 2017-11-14
$72.03K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$21.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28
$48.91K
derived: sum of 2 quarters · filed 2017-09-28
$51.87K
derived: sum of 3 quarters · filed 2017-09-28
$54.82K
10-K · filed 2017-09-28
2016-03-31$27.57K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15
$30.52K
derived: sum of 2 quarters · filed 2017-05-15
$33.48K
10-Q · filed 2017-05-15
$36.78K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$2.96K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10
$5.91K
10-Q · filed 2017-02-10
$9.21K
derived: sum of 3 quarters · filed 2017-02-10
$11.66K
derived: sum of 4 quarters · filed 2017-02-10
2015-09-30$2.95K
10-Q · filed 2016-11-10
$6.26K
derived: sum of 2 quarters · filed 2016-11-10
$8.71K
derived: sum of 3 quarters · filed 2016-11-10
$8.62K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$3.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09
$5.75K
derived: sum of 2 quarters · filed 2016-09-09
$5.66K
derived: sum of 3 quarters · filed 2016-09-09
$9.26K
10-K · filed 2016-09-09
2015-03-31$2.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09
$2.35K
derived: sum of 2 quarters · filed 2016-05-09
$5.95K
10-Q · filed 2016-05-09
$8.23K
derived: sum of 4 quarters · filed 2016-05-09
2014-12-31-$93.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05
$3.50K
10-Q · filed 2016-02-05
$5.78K
derived: sum of 3 quarters · filed 2016-02-05
$5.83K
derived: sum of 4 quarters · filed 2016-02-05
2014-09-30$3.59K
10-Q · filed 2015-11-06
$5.87K
derived: sum of 2 quarters · filed 2015-11-06
$5.92K
derived: sum of 3 quarters · filed 2015-11-06
2014-06-30$2.28K
derived: 10-K 6 month − 8-K 3 month · filed 2015-09-11
$2.33K
10-K · filed 2015-09-11
2014-03-31$50.00
8-K · filed 2014-05-27
$373.00
10-Q · filed 2015-05-15
$423.00
8-K · filed 2014-05-27
2013-12-31$373.00
10-Q · filed 2015-02-13
$373.00
10-K · filed 2015-09-11
$373.00
8-K · filed 2014-05-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63